92 related articles for article (PubMed ID: 32074709)
1. [Evaluation the triage performance of p16/Ki-67 dual staining for HR-HPV positive women].
Jia MM; Zhao DM; Guo Z; Wu ZN; Chen PP; Guo PP; Sun XY; Zhang SK
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Feb; 54(2):192-197. PubMed ID: 32074709
[No Abstract] [Full Text] [Related]
2. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China.
Zhang SK; Jia MM; Zhao DM; Wu ZN; Guo Z; Liu YL; Guo PP; Chen Q; Cao XQ; Liu SZ; Chen W; Sun XB
Cancer Epidemiol; 2019 Apr; 59():123-128. PubMed ID: 30739069
[TBL] [Abstract][Full Text] [Related]
3. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
[No Abstract] [Full Text] [Related]
4. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
[TBL] [Abstract][Full Text] [Related]
5. Clinical Performance of Triage Strategies for Hr-HPV-Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping.
Stanczuk G; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1492-1498. PubMed ID: 35511738
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.
Ebisch RM; van der Horst J; Hermsen M; Rijstenberg LL; Vedder JE; Bulten J; Bosgraaf RP; Verhoef VM; Heideman DA; Snijders PJ; Meijer CJ; van Kemenade FJ; Massuger LF; Melchers WJ; Bekkers RL; Siebers AG
Mod Pathol; 2017 Jul; 30(7):1021-1031. PubMed ID: 28304400
[TBL] [Abstract][Full Text] [Related]
7. Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.
Wright TC; Stoler MH; Ranger-Moore J; Fang Q; Volkir P; Safaeian M; Ridder R
Int J Cancer; 2022 Feb; 150(3):461-471. PubMed ID: 34536311
[TBL] [Abstract][Full Text] [Related]
8. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China.
Rezhake R; Chen F; Hu SY; Zhao XL; Zhang X; Cao J; Qiao YL; Zhao FH; Arbyn M
Int J Cancer; 2020 Oct; 147(8):2053-2064. PubMed ID: 32249409
[TBL] [Abstract][Full Text] [Related]
9. Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus-Positive Women.
Chu B; Dong J; Chen Y; Ru X; Zhang W; Chen Y; Zhang X; Cheng X
J Low Genit Tract Dis; 2023 Oct; 27(4):331-336. PubMed ID: 37589311
[TBL] [Abstract][Full Text] [Related]
10. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.
Luttmer R; Dijkstra MG; Snijders PJ; Berkhof J; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
Mod Pathol; 2016 Aug; 29(8):870-8. PubMed ID: 27150161
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive testing by cytology, p16/Ki-67 dual-stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen-positive women.
Torres-Ibarra L; Lorincz AT; Wheeler CM; Cuzick J; Hernández-López R; Spiegelman D; León-Maldonado L; Rivera-Paredez B; Méndez-Hernández P; Lazcano-Ponce E; Salmerón J
Int J Cancer; 2021 May; 148(9):2264-2273. PubMed ID: 33252834
[TBL] [Abstract][Full Text] [Related]
12. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical performance of p16/Ki-67 dual-staining cytology for cervical lesion detection in premenopausal and postmenopausal Chinese women.
Dai Y; Chen T; Li X; Zhang C; Li T; Zhao Y; Wang Y; Chen S; Yu L; Jiang M; Wu Z; Yang J; Chen W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10645-10658. PubMed ID: 37302113
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
Gustinucci D; Benevolo M; Cesarini E; Mancuso P; Passamonti B; Giaimo MD; Corvetti R; Nofrini V; Bulletti S; Malaspina M; Tintori B; Giorgi Rossi P;
Int J Cancer; 2022 Mar; 150(6):952-960. PubMed ID: 34706093
[TBL] [Abstract][Full Text] [Related]
15. The effect of p16/Ki-67 and p16/mcm2 on the detection of cervical intraepithelial neoplasia: a prospective study from China.
Liao GD; Kang LN; Li J; Zeng X; Chen W; Xi MR
Int J Clin Exp Pathol; 2018; 11(8):4101-4108. PubMed ID: 31949801
[TBL] [Abstract][Full Text] [Related]
16. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of p16/Ki-67 immunocytochemical dual staining in cervical cancer screening].
Wang HR; Liao GD; Chen W; Qiao YL; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):636-640. PubMed ID: 28835090
[No Abstract] [Full Text] [Related]
18. Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
Srisuttayasathien M; Kantathavorn N; Luasiripanthu T; Petchjorm S; Samrarn J; Ittiamornlert P; Krisorakun W; Vanichtantikul A; Wetcho T; Saeloo S
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):192-198. PubMed ID: 38485314
[TBL] [Abstract][Full Text] [Related]
19. p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening.
Magkana M; Mentzelopoulou P; Magkana E; Pampanos A; Vrachnis N; Kalafati E; Daskalakis G; Domali E; Thomakos N; Rodolakis A; Anagnou NP; Pappa KI
Anticancer Res; 2022 May; 42(5):2599-2606. PubMed ID: 35489732
[TBL] [Abstract][Full Text] [Related]
20. [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
Zhang SK; Zhao DM; Chen HM; Guo Z; Ren LY; Jia MM; Chang JJ; Chen PP; Liu SZ; Sun XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Sep; 52(9):941-945. PubMed ID: 30196643
[No Abstract] [Full Text] [Related]
[Next] [New Search]